Tag Archives: Swayampakula Ramakanth

Analysts’ Top Healthcare Picks: Alphatec Holdings (ATEC), Karyopharm Therapeutics (KPTI)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alphatec Holdings (ATEC – Research Report) and Karyopharm Therapeutics (KPTI – Research Report) with bullish sentiments. Alphatec Holdings (ATEC) H.C. Wainwright analyst

H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Verastem (VSTM – Research Report), with a price target of $2.50. The company’s shares closed last Monday at $1.72. According to TipRanks.com, Ramakanth has 0

H.C. Wainwright Initiates a Buy Rating on X4 Pharmaceuticals (XFOR)

H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage with a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) today and set a price target of $22.00. The company’s shares closed last Monday at $10.39, close to its 52-week low of

Analysts Offer Insights on Consumer Goods Companies: Codexis (NASDAQ: CDXS) and Limoneira Co (NASDAQ: LMNR)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Codexis (CDXS – Research Report) and Limoneira Co (LMNR – Research Report) with bullish sentiments. Codexis (CDXS) H.C. Wainwright analyst Swayampakula

Cellectar Biosciences (CLRB) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Cellectar Biosciences (CLRB – Research Report) today and set a price target of $3.00. The company’s shares closed last Monday at $1.93. According to TipRanks.com, Ramakanth ‘s ranking currently consits

Ziopharm Oncology (ZIOP) Gets a Buy Rating from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Ziopharm Oncology (ZIOP – Research Report), with a price target of $6.50. The company’s shares closed last Monday at $5.21. According to TipRanks.com, Ramakanth has